Micro-credential
This Micro-credential Short Course Medical Devices corresponds to module 12 of the DAS in Management of Clinical Trials and MAS Drug Discovery and Clinical Development.
Overview
Objectives
- Understand the regulatory and legal aspects of new Swiss and EU regulations governing medical devices, including Swiss Federal Medical Ordinance (MDO), Medical Device Regulation (MDR) and In Vitro Diagnostic Regulation (IVDR), including certifications and submissions to competent bodies and authorities.
- Learn about the qualification and classification of medical devices under the new regulations.
- Gain knowledge of clinical investigation requirements and the process of submitting clinical trial applications to regulatory authorities.
- Develop strategies for market access, including navigating regulatory pathways and obtaining necessary approvals.
- Familiarise with conformity assessment procedures and the CE marking process for medical devices.
- Understand the principles and practices of materiovigilance for monitoring and reporting adverse events related to medical devices.
- Explore the role of digital health and medical software in the context of medical device regulation.
- Learn about combination products and the regulatory considerations involved in their development and approval.
Audience
Learning outcomes
- Ability to interpret and apply EU regulations (MDR, IVDR) to medical device development and management.
- Ability to classify medical devices according to regulatory requirements.
- Competence in planning and conducting clinical investigations and preparing clinical trial applications for regulatory submission.
- Skill in developing market access strategies and obtaining regulatory approvals for medical devices.
- Proficiency in conducting conformity assessments and ensuring compliance with CE marking requirements.
- Understanding of materiovigilance principles and practices for ensuring the safety of medical devices.
- Knowledge of digital health technologies and their regulatory implications in the medical device industry.
- Ability to navigate regulatory requirements for combination products and ensure compliance throughout the development process.
Registration
Registration deadline
Fees:
CHF 1,400
Admission criteria
a) Holders of a university master's degree or doctorate in science, medicine or pharmacy or a qualification deemed equivalent;
or a bachelor's degree in nursing from a Swiss University of Applied Sciences;
or a qualification deemed equivalent or professional experience deemed equivalent by the programme directors.
b) Good oral and written comprehension of English (equivalent to level B2-C1)
Application File
- Copy of identity document
- Curriculum Vitae
- Copies of relevant university degrees
- Covering letter
Curriculum
Period
Teaching hours
Microcertification
Assessment
Intervenant-es
- Andrea Lopes, Confinis AG
- Corinne Lebourgeois, MedC. Partners
- Fabiana Tirone, Clinical Trial Materio/Phamacovigilance Vigilance, HUG
- Didier Falconnet, Medical Devices & IVD Product Development expert
- Gabriel Avigdor, Attorney-at-law & Legal Director
- Markus Angst, Regulatory and tech consultant, ISS AG
- Mariagrazia Di Marco, Regulatory affairs specialist, CTU, HUG
- Marie Gaumet, Managing Director, SwAPP
- Rima Padovani, Director, Quality & Regulatory Affairs
Partnerships / Collaboration
Accreditation / Recognition / Certification
Director(s)
Prof. Youssef DAALI and Prof. François CURTIN, Faculty of Science and Faculty of Medicine, University of Geneva
Coordinator(s)
Steering committee
- Prof. Gerrit BORCHARD, President of the Section of Pharmaceutical Sciences (ISPOS), Faculty of Science, University of Geneva
- Prof Alexandra CALMY, Vice-Dean of clinical research, Director of the Clinical Research Centre (CRC), Head of HIV/AIDS Unit, Associate Physician, Dept of Infectious Diseases, Geneva University Hospitals
- Prof Youssef DAALI, Head of the Pharmacological Investigation Unit, Geneva University Hospitals, Faculty of Medicine, University of Geneva
- Prof Samia HURST, Director, Institute of Ethics, History and Humanities (iEH2), Faculty of Medicine, University of Geneva
- Dr Pierre-Yves MARTIN, President, Catonal Commission on Human Research Ethics, Canton of Geneva
- Prof Klara POSFAY BARBE, Medical Director, Geneva University Hospitals
Scientific committee
- Dr Emilie ALIROL, Senior Director Clinical Affairs, FIND
- Dr Enrica ALTERI, Pharmaceutical consultant, former Head of Human Medicine R&D Support Division EMA
- Prof. Francois CURTIN, Head of the Centre for Clinical Research, Lucerne Cantonal Hospital (LUKS), Lecturer at Geneva University Hospitals, University of Geneva
- Prof Youssef DAALI, Head of the Pharmacological Investigation Unit. Geneva University Hospitals, Faculty of Medicine, University of Geneva
- Dr Catherine DELOCHE, Chief Operating Officer, Solid Drug Development,Geneva
- Prof Jules DESMEULES, Faculty of Medicine, University of Geneva
- Prof Marc FROISSART, Chief Medical Director of the Clinical Research (CRC), CHUV-UNIL, Lausanne
- Dr Angèle GAYET-AGERON, Full Professor in Epidemiology and Public Health & Director of the Institute of Social and Preventive Medicine (ISPM) at University of Bern
- Dr Brigitte HAPP, External Consultant
- Dr Cyril JAKSIC, Statistician, Methodological Support unit, Clinical Research Centre (CRC), Geneva University Hospitals
- Dr Françoise LASCOMBES, External Consultant
- Dr Guillaume PERRIARD, PhD, Lead Patient Engagement, Novartis, Basel
- Dr Victoria ROLLASON, PharmD, Division of Clinical Pharmacology and Toxicology, University Hospitals of Geneva and Faculty of Medicine, University of Geneva
Related programmes
- MAS - Drug Discovery and Clinical Development (2025)
- DAS - Management of Clinical Trials (2025)
- Module - Management of Clinical Trials – Ethical and Regulatory Aspects (2025)
- Module - Management of Clinical Trials – Medical Statistical and Trial Methodologies (2025)
- Module - Management of Clinical Trials – Clinical Trials Set-up and Conduct (2026)
- Module - Management of Clinical Trials – Clinical Trial Conduct and Close-out (2026)
- Module - Management of Clinical Trials – Audits and Inspections (2026)
- Module - Management of Clinical Trials – Regulatory Strategy and Procedures in Product Development (2026)